Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Leukemia|February 1, 1995
Acute leukemia coexpressing myeloid, B- and T-lineage associated markers: multiparameter analysis of criteria defining lineage commitment and maturational stage in a case of undifferentiated leukemiaG Meckenstock, A Heyll, E M Schneider, et al.
British Journal of Haematology|August 16, 2005
High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised studyR Fenk, P Schneider, M Kropff, et al.
Annals of Hematology|February 1, 1997
Acquired factor VIII inhibitors in nonhemophilic patientsD Söhngen, C Specker, D Bach, et al.
Leukemia & Lymphoma|June 27, 1998
Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significanceG Meckenstock, C Aul, B Hildebrandt, et al.
Annals of Hematology|November 7, 1999
Factors influencing G-CSF-mediated mobilization of hematopoietic progenitor cells during steady-state hematopoiesis in patients with malignant lymphoma and multiple myelomaG Kobbe, D Söhngen, U Bauser, et al.
Leukemia|January 22, 1998
Idarubicin, melphalan and cyclophosphamide: an intensified high-dose regimen for the treatment of myeloma patientsA Heyll, D Söhngen, G Kobbe, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 11, 1999
Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center reportH J Laws, S Burdach, B van Kaick, et al.
Blood|June 11, 1999
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative GroupT Büchner, W Hiddemann, B Wörmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, AustriaS Burdach, B van Kaick, H J Laws, et al.
Blood|September 10, 1998
Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89W D Ludwig, H Rieder, C R Bartram, et al.
Pageof 7